Literature DB >> 27737444

Association Between Adherence to Glasses Wearing During Amblyopia Treatment and Improvement in Visual Acuity.

Gail D E Maconachie1, Shegufta Farooq2, Glen Bush3, Julie Kempton3, Frank A Proudlock1, Irene Gottlob1.   

Abstract

IMPORTANCE: Occlusion dose monitors have helped establish that better adherence to occlusion is associated with improved visual outcomes in patients undergoing amblyopia treatment. However, the role of adherence to glasses wearing is unknown.
OBJECTIVES: To establish the feasibility and reliability of objectively monitoring adherence to glasses wearing using age-based norms, establish the association between adherence to glasses wearing and improvement in visual acuity (VA) after optical treatment and occlusion therapy, and analyze the effect of age, sex, refractive errors, type of amblyopia, and adherence to glasses wearing on improvement in VA. DESIGN, SETTING, AND PARTICIPANTS: A prospective, observational, nonmasked, cohort study was conducted between June 8, 2008, and June 30, 2013, among patients at a pediatric ophthalmology clinic of a tertiary care hospital who were newly diagnosed with anisometropic and/or strabismic amblyopia and had not undergone previous treatment. The study consisted of a glasses phase (18 weeks) and a patching phase (glasses and occlusion for 10 hours per day for 12 weeks). Reliability of the glasses monitors was assessed by comparing diary entries and monitor recordings in adults.
INTERVENTIONS: Objective monitoring of glasses wearing and occlusion. MAIN OUTCOMES AND MEASURES: Adherence to glasses wearing (hours per day) and effect on VA.
RESULTS: Among 20 children with anisometropia (mean [SD] age, 6.20 [2.16] years; 11 boys and 9 girls) and 20 with strabismic or mixed amblyopia (mean [SD] age, 4.90 [1.36] years; 10 boys and 10 girls), adherence to glasses wearing was successfully monitored in all but 1 patient. Agreement between diaries and monitored times wearing glasses in adults was high (intraclass correlation coefficient, 1.00; 95% CI, 0.999-1.00). Median (SD) adherence to glasses wearing was 70% (25.3%). A moderate correlation was observed between adherence to glasses wearing and percentage improvement in VA during the glasses phase (r = 0.462; P = .003). Multiple regression revealed that age (β = -0.535; P = .001), type of amblyopia (β = -0.347; P = .02), and adherence to glasses wearing (β = 0.287; P = .04) were independently associated with improvement in VA after the glasses phase and explained 42% of the variability (F3,35 = 8.457; P < .001). A strong correlation between glasses wearing and occlusion adherence was observed (r = 0.719; P < .001). CONCLUSIONS AND RELEVANCE: The results suggest that adherence to glasses wearing is less than optimal and highly variable but is important in achieving good VA. This study emphasizes the importance of encouraging children to not only have good adherence to occlusion therapy but also to glasses wearing.

Entities:  

Mesh:

Year:  2016        PMID: 27737444     DOI: 10.1001/jamaophthalmol.2016.3793

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  8 in total

Review 1.  [Treatment monitoring and innovations in amblyopia treatment].

Authors:  Kai Januschowski; Caroline Emmerich; Annegret Abaza; Henrike Julich-Haertel; Annekatrin Rickmann
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

2.  Spectacle Adherence Among Four-Year-Old Children in the Infant Aphakia Treatment Study.

Authors:  Scott R Lambert; Lindreth DuBois; George Cotsonis; E Eugenie Hartmann; Carolyn Drews-Botsch
Journal:  Am J Ophthalmol       Date:  2019-01-08       Impact factor: 5.258

3.  Regional Downregulation of Dopamine Receptor D1 in Bilateral Dorsal Lateral Geniculate Nucleus of Monocular Form-Deprived Amblyopia Models.

Authors:  Dongyue Lin; Zhonghao Wang; Wei Chen; Tao Shen; Xuan Qiu; Kun Wei; Jiahui Li; Dongsheng Yang; Ping Wang; Xuri Li; Jianhua Yan; Zhongshu Tang
Journal:  Front Neurosci       Date:  2022-06-08       Impact factor: 5.152

4.  Measuring aniseikonia and investigating neuroplasticity and image factors in amblyopia (MAGNIFY): study protocol for a randomised clinical trial.

Authors:  Jayshree South; Tina Gao; Melinda Calderwood; Jason Turuwhenua; Paul Roberts; Arier Lee; Andrew Collins; Joanna Black
Journal:  Trials       Date:  2022-04-27       Impact factor: 2.728

5.  Objective measurement of spectacle wear with a temperature sensor data logger.

Authors:  Matthew J Lentsch; Jason D Marsack; Heather A Anderson
Journal:  Ophthalmic Physiol Opt       Date:  2017-11-08       Impact factor: 3.117

6.  Improved monitoring of adherence with patching treatment using a microsensor and Eye Patch Assistant.

Authors:  Jingyun Wang; Hongxin Xu; Bryan De La Cruz; Sarah E Morale; Reed M Jost; David A Leske; Jonathan M Holmes; Eileen E Birch
Journal:  J AAPOS       Date:  2020-03-18       Impact factor: 1.220

7.  Objective Monitoring of Spectacle Wearing Times in Adult Subjects Using the Theramon® Thermosensor.

Authors:  Annegret Abaza; Gideon Wahl; Constanze Kortüm; Kai Januschowski; Dorothea Besch; Charlotte Schramm
Journal:  Clin Ophthalmol       Date:  2021-03-31

8.  Qualitative study investigating the perceptions of parents of children who failed vision screening at the age of 4-5 years.

Authors:  Alison Bruce; Tom Sanders; Trevor A Sheldon
Journal:  BMJ Paediatr Open       Date:  2018-09-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.